ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Mar 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
April 2026
Latest News
Von der Leyen shares regrets, growth plans at European nuclear summit
In 1990, 30 percent of Europe’s electricity came from nuclear power plants. In 2026, it is closer to 15 percent.
European Commission President Ursula von der Leyen lamented the decline of nuclear energy, calling it a “strategic mistake” when Europe turned its back on a “reliable, affordable source of low-emissions power.”
Marta Velarde, Jose Manuel Perlado
Fusion Science and Technology | Volume 43 | Number 3 | May 2003 | Pages 484-491
Technical Paper | Safety and Environment | doi.org/10.13182/FST03-A295
Articles are hosted by Taylor and Francis Online.
The evaluation of the radiological environmental impact of tritium emission to the atmosphere from inertial fusion energy (IFE) reactors has different chronological phases. In the release primary phase, the important factors are the boundary conditions: atmospheric and geometric grid from the point of emission. The second phase occurs when the tritium is deposited in the ground. This phase is important in order to account for the dosimetric effects of tritium, and it is a key factor in the chronic and collective doses of the population.The final internal irradiation dose is calculated as the addition of doses by ingestion, by inhalation of the primary plume, by absorption on the skin, and inhalation by reemission to the atmosphere.Each of the two chemical forms (HT and HTO) of tritium present in the environment from potential IFE reactor releases contributes in different ways to the most exposed individual and the committed effective dose equivalent (50-CEDE). The HTO presents a much larger percentage of the internal irradiation from inhalation and absorption through the skin than HT. However, in releases where HT represents 100%, the contributions to the total effective dose by ingestion and reemission are important.